Narvitas Medical Devices :: Introducing LapDome

1. Corporate Presentation
January 2015

2. Clinical Problem
• Initial Access using a Veress needle has not
changed in 30 years
• Complications rates are frequent and very
expensive
• Time to insufflation!

3. Opportunity
• Simple innovation to allow safe and fast access
to abdomen
• 9 million procedures using Veress needle
every year
• Growing 10% per annum
• Distributor friendly single use device

4. Solution – ‘LapDome’
• Clinical superiority
• Improves current standard of care
• Improves patient safety
• Improved insufflation rates
• Reduced operating theatre budgets
• Reducing potential complications
rates

5. Narvitas Medical Devices
• Develop, patent, manufacture and sell propriety medical
devices
• 3 Initial Platforms, each leveraging the core technology
• Class 1 - Large market segment – High Volume procedures
Laparoscopic Epidural Anesthesia Med
Surg
15 mil procedures
worldwide
130 mil births In dwelling catheter
collection
EpiDome Jaws

6. Team
Glenn Foley Co-Founder & CEO
AVE – Medtronic -
Precision Vascular
Daragh Sharkey Co-Founder & Director
Sales Mkt and Bus Dev
Aerogen, Altana, Trojan Med
Arthur Malvett Co-Founder & Director
Operations and Logistics
Life Care Medical, Midland
Bank

7. Advisors
• Dr. Aidan Sharkey
– Consultant Anesthetist UCHG – Specialty OBGYN
• Dr. Una Conway
– Consultant OBGYN – Specialty in Laparoscopic Surgery
• Dr. Michael O’Dowd
– Retired Consultant OBGYN – Pioneered Laparoscopic Surgery in UK / Irl –
Author of 3 medical texts and numerous research papers
• Mr. Jerome Nathan
– CFO Centilex Corp, LLB University Paris, ACCA University Paris
• Mr. Alan Crean
– CEO Poly Pico Medical, CEO Pointec Medical, Director Creganna

8. Professional Advisors
€452k
Subscribed
€298k
Open
€2.3m
Valuation

9. Intellectual Property
Laparoscopic Surgery
National Phase Patent Application Number Patent Publication Number
US 13/640,015 US2013-0197315A1
Europe 10849757.9 EP2558006A1
Japan P2013-504347 P2013-523370A
Australia 2010351314
AU2010351314A1
South Korea 10-2012-7029658 10-20-130076816
UK GB1408740.7
Epidural Anesthesia
UK GB1409553.3

10. Distributor Strategy - EMEA
• UK, Ireland, Benelux Q2 – key hospitals and doctors identified
• Key distributors identified – specific expertise in GYN medical devices
• Clinical Backup
• Enterprise Ireland support and back up – key meetings, distributor
selection
• Strategic focus on UAE / Saudi Arabia

11. Distributor Strategy - USA
• US Laparoscopic Surgery Veress based procedure volume: 6,000,000 procedures
Surgical Principals Inc Active Medical
EA Medical AMSC
CS Surgical Adler Instruments
Mediflex USA
Support Programs
• Europe/ME referral centers
• White papers
• Registry
• Published papers
• Economic Impact analysis

12. Product Pipeline and Timing
Device Class CE FDA JMOH
I CQI 2015 CQ4 2015 CQI 2016
2A Kits inc Veress CQ4 2015 CQ2 2016 CQ4 2016
EpiDome
CQ3 2015
CQ4 2015
CQI 2016
CQ1 2016
CQ1 2016
CQ3 2016
CQ2 2016
CQ2 2016
CQ4 2016

13. Financial Forecast
FY2015* FY2016** FY2017***
Sales Revenue €0 €1,585 €9,721
CGS €0 €287 €2,149
GP €0 €1,261 €7,419
OPEX €-232 €459 €1,116
EBITDA €-238 €802 (52%) €6,375 (66%)
* Europe
** Europe +US + Latin America
*** Europe +US + Latin America + Japan

14. Liquidity and Exit